Method for cellular restoration
AssigneeAdvanced ReGen Medical Technologies, LLC
InventorVincent C. Giampapa
Life of this patent
Estimating the term…
Abstract
A method comprising obtaining a donor composition from a donor subject wherein the donor composition comprises a plurality of adult stem cell types; obtaining a receiver composition from a receiver subject wherein the receiver composition comprises a plurality of adult stem cell types; and co-culturing the donor composition and receiver composition wherein co-culturing comprises contacting the receiver composition a cell-free portion of the donor composition to produce a restored composition. Pharmaceutical compositions comprising a restored composition.
Claims24
A method of restoring adult stem cells comprising:
- obtaining a donor composition from a donor subject wherein the donor composition comprises a plurality of adult stem cell types;
- obtaining a receiver composition from a receiver subject wherein the receiver composition comprises a plurality of adult stem cell types and wherein the donor subject and receiver subject differ in chronological age by from about 5 years to about 75 years;
- culturing the donor composition in a media for a time period ranging from about 1 hour to about 90 days wherein culturing the donor composition results in the production of secreted vesicles, microvesicles, cell-derived soluble vesicle compartments, cell-derived soluble factors, or a combination thereof;
- separating the adult stem cell types in the donor composition from the media to produce a cell-free donor composition wherein separating comprises filtering the cells in the donor composition through a permeable membrane;
- and
- co-culturing the cell-free donor composition and receiver composition wherein co-culturing comprises contacting the receiver composition with the cell-free donor composition to produce a restored composition wherein the restored composition comprises cells that display an altered expression of at least one gene selected from the group consisting of GPX-1 (encoding for glutathione peroxidase-1), SOD 1 (encoding for superoxide dismutase-1);
- REL-A (encoding for p65 of the NFKB heterodimer);
- LIG-4 (encoding for DNA Ligase-4);
- GLB-1 (encoding for —galactosidase) and p16INK4 and wherein the altered expression comprises a change in the expression level of the at least one gene of at least 1.5 fold.
Dependencies are inferred from the claim text.